

Capsules
1 caps contains 3- (2,2,2-trimethylhydrazinium) propionate dihydrate 100 mg
40 pcs.
Cardionate has a metabolic, cardioprotective, antianginal, antihypoxic, adaptogenic, improves cerebral circulation effect.
Reduced performance; physical overvoltage, incl. athletes; the postoperative period to accelerate rehabilitation. As part of complex therapy - ischemic heart disease (angina pectoris, myocardial infarction), chronic heart failure, cardialgia on the background of myocardial dyshormonal dystrophy, acute and chronic disorders of cerebral circulation (stroke, cerebrovascular failure). Withdrawal syndrome in chronic alcoholism (in combination with specific therapy). In ophthalmology - hemophthalmus and retinal hemorrhages of various etiologies, thrombosis of the central vein of the retina and its branches, retinopathy of various etiologies (diabetic, hypertensive) - only for parabulbar injection.
Hypersensitivity, increased intracranial pressure (in violation of the venous outflow, intracranial tumors). Pregnancy, breastfeeding, children under 18 years.
Cardionate used inside. The doses and duration of the course of treatment are set individually depending on the indications, the severity of the condition, and others. The average dose of Cardionate for adults: when taken orally, 250 mg 2-4 times a day. Athletes are prescribed by special schemes in combination with other means.
Dyspepsia, agitation, tachycardia, hypotension, pruritus.
In the dark place at a temperature of 25 ° C.
Cardionate